Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 34, Issue 6, 2011, Pages 573-580

  Cheng, Lee ^a   Eng, Cathy ^a   Nieman, Linda Z ^b   Kapadia, Asha S ^c   Du, Xianglin L ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

colorectal cancer; distal colon; incidence; proximal colon; rectal cancer; trend

Indexed keywords

ADULT; AGED; ARTICLE; ASCENDING COLON; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER STAGING; COLORECTAL CANCER; DESCENDING COLON; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RECTUM; SEX DIFFERENCE; UNITED STATES;

AGE DISTRIBUTION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; SEER PROGRAM; SEX FACTORS; UNITED STATES;

EID: 81855163394     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181fe41ed     Document Type: Article

References (37)

1. Centers for Disease Control and Prevention. United States Cancer Statistics: 2004 Incidence and Mortality. Executive Summary. Available at: http://www.cdc.gov/cancer/NPCR/npcrpdfs/uscs-2004- executive-summary.pdf. Accessed January 15, 2009.
2. Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2009. CA Cancer J Clin. 2009;59:225-249.
3. Surveillance Epidemiology and End Results (SEER). Table II-1 All Cancer Sites (Invasive) Trends In SEER Incidence and U.S. Mortality Using The Joinpoint Regression Program, 1975-2005 With up To Three Joinpoints By Race And Sex. Available at: http://seer.cancer.gov/csr/1975-2005/results-merged/sect-02-all- sites.pdf. Accessed January 20, 2009.
4. Ransohoff DF. Colon cancer screening in 2005: status and challenges. Gastroenterology. 2005;128:1685-1695.
5. Singh H, Turner D, Xue L, et al. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA. 2006;295: 2366-2373.
6. Cress RD, Morris C, Ellison GL, et al. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ ethnicity, 1992-2001. Cancer. 2006;107:1142-1152.
7. Phillips KA, Liang SY, Ladabaum U, et al. Trends in colonoscopy for colorectal cancer screening. Med Care. 2007;45:160-167.
8. Wu X, Cokkinides V, Chen VW, et al. Associations of subsitespecific colorectal cancer incidence rates and stage of disease at diagnosis with county-level poverty, by race and sex. Cancer. 2006;107(suppl 5):1121-1127.
9. Baker AH, Wardle J. Increasing fruit and vegetable intake among adults attending colorectal cancer screening: the efficacy of a brief tailored intervention. Cancer Epidemiol Biomarkers Prev. 2002; 11:203-206.
10. Miles A, Wardle J, McCaffery K, et al. The effects of colorectal cancer screening on health attitudes and practices. Cancer Epidemiol Biomarkers Prev 2003;12:651-655.
11. Rabeneck L, Davila JA, El-Serag HB. Is there a true "shift" to the right colon in the incidence of colorectal cancer? Am J Gastroenterol 2003;98:1400-1409.
12. Walker J, Quirke P. Prognosis and response to therapy in colorectal cancer. Eur J Cancer. 2002;38:880-886.
13. Skegg DC, McCredie MR. Comparison of cancer mortality and incidence in New Zealand and Australia. N Z Med J. 2002;115: 205-208.
14. Landry CS, Brock G, Scoggins CR, et al. Proposed staging system for colon carcinoid tumors based on an analysis of 2459 patients. J Am Coll Surg. 2008;207:874-881.
15. Surveillance Epidemiology and End Results (SEER). SEER Limited-Use Data, 1973-2005 (9, 13, and 17 Registries Databases). Bethesda, MD: National Cancer Institute; 2008.
16. Surveillance Epidemiology and End Results (SEER). Surveillance Research Program, National Cancer Institute SEER. * Stat software (www.seer.cancer.gov/seerstat) version 6.4.4.; 2008.
17. Young JL Jr, Roffers SD, Ries LAG, et al. SEER Summary Staging Manual-2000: Codes and Coding Instructions, National Cancer Institute, NIH Pub. No. 01-4969. Bethesda, MD: National Cancer Institute; 2001.
18. Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:627-637.
19. Okamoto M, Shiratori Y, Yamaji Y, et al. Relationship between age and site of colorectal cancer based on colonoscopy findings. Gastrointest Endosc. 2002;55:548-551.
20. Slater G, Papatestas AE, Tartter PI, et al. Age distribution of rightand left-sided colorectal cancers. Am J Gastroenterol. 1982;77: 63-66.
21. Gonzalez EC, Roetzheim RG, Ferrante JM, et al. Predictors of proximal versus distal colorectal cancers. Dis Colon Rectum. 2001;44:251-258.
22. Chu KC, Tarone RE, Chow WH, Alexander GA. Colorectal cancer trends by race and anatomic subsites, 1975 to 1991. Arch Fam Med. 1995;4:849-856.
23. Gross CP, Andersen MS, Krumholz HM, et al. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA. 2006;296:2815-2822.
24. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med. 1990;113:779-788.
25. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 1993;260:816-819.
26. Limburg PJ, Anderson KE, Johnson TW, et al. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev. 2005;14:133-137.
27. Weiderpass E, Gridley G, Nyren O, et al. Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst. 1997;89: 660-661.
28. Levi F, Pasche C, Lucchini F, et al. Diabetes mellitus, family history, and colorectal cancer. J Epidemiol Community Health. 2002;56:479-480.
29. Moradi T, Gridley G, Björk J, et al. Occupational physical activity and risk for cancer of the colon and rectum in Sweden among men and women by anatomic subsite. Eur J Cancer Prev. 2008;17: 201-208.
30. Potter JD, McMichael AJ. Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study. J Natl Cancer Inst. 1983;71:703-709.
31. Miyakura Y, Sugano K, Konishi F, et al. Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability. Gastroenterology. 2001;121:1300-1309.
32. Lindblom A. Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol. 2001;13:63-69.
33. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977-1981.
34. McDonnell WM, Loura F. Complications of colonoscopy. Ann Intern Med. 2007;147:212-213. [Author reply 213-214].
35. Meissner HI, Breen N, Klabunde CN, et al. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15:389-394.
36. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570-1595.
37. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009;59:27-41.